{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:17:05Z","timestamp":1778692625332,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010731","name":"Faculty of Medicine, Chiang Mai University","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100010731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>We evaluated the long-term outcomes and late toxicity of conventional fractionated (CF) and hypofractionated (HF) postmastectomy radiotherapy (PMRT) in terms of locoregional recurrence-free survival (LRRFS), disease-free survival (DFS), overall survival (OS), and late toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cohort of 1640 of breast cancer patients receiving PMRT between January 2004 and December 2014 were enrolled. Nine hundred eighty patients were treated with HF-PMRT: 2.65\u2009Gy\/fraction to a total of 42.4\u201353\u2009Gy and 660 patients were treated with CF-PMRT: 2\u2009Gy\/fraction to a total of 50\u201360\u2009Gy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median follow-up time was 71.8\u2009months (range 41.5\u2013115.9\u2009months). No significant difference was found in the rates of 5-year LRRFS, DFS, and OS of HF-PMRT vs CF-PMRT; 96% vs. 94% (<jats:italic>p<\/jats:italic>\u2009=\u20090.373), 70% vs. 72% (<jats:italic>p<\/jats:italic>\u2009=\u20090.849), and 73% vs. 74% (<jats:italic>p<\/jats:italic>\u2009=\u20090.463), respectively. We identified a cohort of 937 eligible breast cancer patients who could receive late toxicities assessment. With a median follow-up time of this patient cohort of 106.3\u2009months (range 76\u2013134\u2009months), there was a significant higher incidence of grade 2 or more late skin (4% vs 1%) and subcutaneous (7% vs 2%) toxicity in patients treated with HF-PMRT vs CF-PMRT. Patients who received additional radiation boost were significantly higher in the HF-PMRT group. Grade 2 or more late RTOG\/EORTC lung toxicity was significant lesser in HF-PMRT vs CF-PMRT (9% vs 16%). Grade 1 brachial plexopathy was also significant lesser in HF-PMRT vs CF-PMRT (2% vs 8%). Heart toxicity and lymphedema were similar in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HF<jats:bold>-<\/jats:bold>PMRT is feasible to deliver with comparable long-term efficacy to CF-PMRT. HF-PMRT had higher grade 2 or more skin and subcutaneous toxicity but less lung and brachial plexus toxicity.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13014-019-1378-x","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T10:03:38Z","timestamp":1571047418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-0149","authenticated-orcid":false,"given":"Imjai","family":"Chitapanarux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pitchayaponne","family":"Klunklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attapol","family":"Pinitpatcharalert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patumrat","family":"Sripan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkasit","family":"Tharavichitkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wannapha","family":"Nobnop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wimrak","family":"Onchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somvilai","family":"Chakrabandhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongkot","family":"Jia-Mahasap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntima","family":"Euathrongchit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutthaphan","family":"Wannasopha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanop","family":"Srisuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"1378_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/jnci\/djh297","volume":"97","author":"J Ragaz","year":"2005","unstructured":"Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116\u201326. https:\/\/doi.org\/10.1093\/jnci\/djh297 .","journal-title":"J Natl Cancer Inst"},{"key":"1378_CR2","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1200\/JCO.2005.02.8738","volume":"24","author":"HM Nielsen","year":"2006","unstructured":"Danish Breast Cancer Cooperative G, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24:2268\u201375. https:\/\/doi.org\/10.1200\/JCO.2005.02.8738 .","journal-title":"J Clin Oncol"},{"key":"1378_CR3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"MCR Clarke","year":"2005","unstructured":"Clarke MCR, Darby S, Davies C, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087\u2013106. https:\/\/doi.org\/10.1016\/S0140-6736(05)67887-7 .","journal-title":"Lancet."},{"key":"1378_CR4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists\u2019 Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8 .","journal-title":"Lancet"},{"key":"1378_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0167-8140(90)90149-Q","volume":"19","author":"HDBS Thames","year":"1990","unstructured":"Thames HDBS, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol. 1990;19:219\u201335.","journal-title":"Radiother Oncol"},{"key":"1378_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0906260 .","journal-title":"N Engl J Med"},{"key":"1378_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","volume":"9","author":"SM Bentzen","year":"2008","unstructured":"START Trialists group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331\u201341. https:\/\/doi.org\/10.1016\/S1470-2045(08)70077-9 .","journal-title":"Lancet Oncol"},{"key":"1378_CR8","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"START Trialists group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098\u2013107. https:\/\/doi.org\/10.1016\/S0140-6736(08)60348-7 .","journal-title":"Lancet"},{"key":"1378_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(13)70386-3 .","journal-title":"Lancet Oncol"},{"key":"1378_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341\u20136. https:\/\/doi.org\/10.1016\/0360-3016(95)00060-C .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1378_CR11","first-page":"1","volume":"46","author":"International Society of Lymphology","year":"2013","unstructured":"International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the International Society of Lymphology. Lymphology. 2013;46:1\u201311.","journal-title":"Lymphology."},{"key":"1378_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.radonc.2004.03.005","volume":"71","author":"A Bajrovic","year":"2004","unstructured":"Bajrovic A, Rades D, Fehlauer F, Tribius S, Hoeller U, Rudat V, et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol. 2004;71:297\u2013301. https:\/\/doi.org\/10.1016\/j.radonc.2004.03.005 .","journal-title":"Radiother Oncol"},{"key":"1378_CR13","first-page":"282","volume":"59","author":"A Shahid","year":"2009","unstructured":"Shahid A, Athar MA, Asghar S, Zubairi T, Murad S, Yunas N. Post mastectomy adjuvant radiotherapy in breast cancer: a comparision of three hypofractionated protocols. J Pak Med Assoc. 2009;59:282\u20137.","journal-title":"J Pak Med Assoc"},{"key":"1378_CR14","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1007\/s12032-012-0192-1","volume":"29","author":"H Eldeeb","year":"2012","unstructured":"Eldeeb H, Awad I, Elhanafy O. Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up. Med Oncol. 2012;29:2570\u20136. https:\/\/doi.org\/10.1007\/s12032-012-0192-1 .","journal-title":"Med Oncol"},{"key":"1378_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000449433","volume":"11","author":"V Kouloulias","year":"2016","unstructured":"Kouloulias V, Mosa E, Zygogianni A, , Kypraiou E, Georgakopoulos J, Platoni K, et al. A retrospective analysis of toxicity and efficacy for 2 hypofractionated irradiation schedules versus a conventional one for post-mastectomy adjuvant radiotherapy in breast cancer. Breast Care 2016;11:328\u2013332. doi: https:\/\/doi.org\/10.1159\/000449433 .","journal-title":"Breast Care"},{"key":"1378_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.11.010","volume":"97","author":"S Bellefqih","year":"2017","unstructured":"Bellefqih S, Elmajjaoui S, Aarab J, Khalil J, Afif M, Lachgar A, et al. Hypofractionated regional nodal irradiation for women with node-positive breast cancer. Int J Radiat Oncol Biol Phys. 2017;97:563\u201370. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.11.010 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1378_CR17","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1200\/JCO.2016.70.7158","volume":"35","author":"AJ Khan","year":"2017","unstructured":"Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, et al. Hypofractionated postmastectomy radiation therapy is safe and effective: first results from a prospective phase II trial. J Clin Oncol. 2017;35:2037\u201343. https:\/\/doi.org\/10.1200\/JCO.2016.70.7158 .","journal-title":"J Clin Oncol"},{"issue":"3","key":"1378_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","volume":"20","author":"SL Wang","year":"2019","unstructured":"Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP, et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019;20(3):352\u201360.","journal-title":"Lancet Oncol"},{"key":"1378_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/apjon.apjon_46_17","volume":"5","author":"K Rastogi","year":"2018","unstructured":"Rastogi K, Jain S, Bhatnagar AR, Bhaskar S, Gupta S, Sharma N. A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients. Asia Pac J Oncol Nurs. 2018;5:107\u201313.","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"Suppl 2","key":"1378_CR20","first-page":"S94","volume":"94","author":"A Pinitpatcharalert","year":"2011","unstructured":"Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, Lorvidhaya V. A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thail. 2011;94(Suppl 2):S94\u2013102.","journal-title":"J Med Assoc Thail"},{"key":"1378_CR21","doi-asserted-by":"publisher","first-page":"20140035","DOI":"10.1259\/bjr.20140035","volume":"87","author":"C Ordonez-Sanz","year":"2014","unstructured":"Ordonez-Sanz C, Bowles S, Hirst A, MacDougall ND. A single plan solution to chest wall radiotherapy with bolus? Br J Radiol. 2014;87:20140035.","journal-title":"Br J Radiol"},{"key":"1378_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1259\/bjr.20140035","volume":"19","author":"TT Vu","year":"2007","unstructured":"Vu TT, Pignol JP, Rakovitch E, Spayne J, Paszat L. Variability in radiation oncologists\u2019 opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey. Clin Oncol (R Coll Radiol). 2007;19:115\u20139. https:\/\/doi.org\/10.1259\/bjr.20140035 Epub 2014 Feb 26.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"1378_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/2278-330X.105885","volume":"2","author":"S Agrawal","year":"2013","unstructured":"Agrawal S. Clinical relevance of radiation pneumonitis in breast cancers. South Asian J Cancer. 2013;2(1):19\u201320.","journal-title":"South Asian J Cancer"},{"key":"1378_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.radonc.2006.12.001","volume":"82","author":"T Rancati","year":"2007","unstructured":"Rancati T, Wennberg B, Lind P, Svane G, Gagliardi G. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Radiother Oncol. 2007;82:308\u201316.","journal-title":"Radiother Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1378-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1378-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1378-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T18:03:42Z","timestamp":1664647422000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1378-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1378"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1378-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}